iShares Healthcare Innovation ETF A
ETF
ETF
ISIN: IE00BYZK4776
Ticker: 2B78
IE00BYZK4776
2B78
Price
Price
CHART BY
Data
TER
- 0.4%
Fund Volume
- $1.09B
Asset Class
- Equity
Distributing
- No
Replication Method
- Physical Sample
Region
- unclassified
Country Based
- Ireland
Issuer
- iShares
Region Breakdown
🇺🇸
USA64.29%🏳️
Other6.68%🇨🇭
Switzerland5.95%🇯🇵
Japan4.73%🇰🇷
Korea4.13%🇳🇱
Netherlands4.02%🇩🇰
Denmark2.52%🇮🇪
Ireland2.26%🇧🇪
Belgium2.16%🇬🇧
United Kingdom1.75%🇰🇾
Cayman Islands1.51%
Sector Breakdown
- Health Care96.96%
- Information Technology2.09%
- Industrials0.57%
- Other0.38%
Frequently asked questions
What is the Total Expense Ratio (TER) of iShares Healthcare Innovation ETF A?
The total expense ratio (TER) of iShares Healthcare Innovation ETF A is 0.4%. The TER represents the annual fees charged by the ETF provider, covering management costs and operational expenses. A lower TER can enhance your investment returns over time.
What is the fund volume of iShares Healthcare Innovation ETF A?
iShares Healthcare Innovation ETF A has a fund volume of $1.09B. Fund volume indicates the total assets under management (AUM) and reflects the ETF's size and liquidity. Larger fund volumes generally offer better liquidity and tighter bid-ask spreads.
Is iShares Healthcare Innovation ETF A paying dividends?
iShares Healthcare Innovation ETF A is a Accumulating ETF. It reinvests dividends back into the fund, increasing the value of each share over time.
What is the replication method used by iShares Healthcare Innovation ETF A?
iShares Healthcare Innovation ETF A employs a physical sampling replication method. This means the ETF holds a representative sample of the securities included in the underlying index, rather than every single security. By selecting a subset that closely mirrors the index's risk and return characteristics, the ETF aims to efficiently replicate the index performance while minimizing transaction costs.
In which country is iShares Healthcare Innovation ETF A domiciled?
iShares Healthcare Innovation ETF A is domiciled in Ireland. The domicile country can affect tax implications and regulatory oversight, which may influence your investment decisions.
Pricing
- 1D span
- $7.45$7.67
- 52W span
- $6.998$8.259
Information
The Fund aims to achieve a return on your investment, through a combination of capital growth and income on the Funds assets, which reflects the return of the STOXX Global Breakthrough Healthcare Index. The Share Class, via the Fund is passively managed, and aims to invest in equity securities (e.g. shares) that, so far as possible and practicable, make up the Index.
Identifier
- ISIN
- IE00BYZK4776
- Primary Ticker
- 2B78